Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Cases Journal|January 12, 2010
A rare case of isolated duodenal metastases from hepatocellular carcinoma associated with p53 and ki-67 expression: a case reportCaroline Chung, Jaber Al Ali, David A Owen, et al.Cancer Biology & Therapy|January 15, 2021
Inhibition of nucleophosmin 1 suppresses colorectal cancer tumor growth of patient -derived xenografts via activation of p53 and inhibition of AKTAngel C Y Yu, Yi-Jye Chern, Peter Zhang, et al.Biochemical and Biophysical Research Communications|February 23, 2010
Protective effects of methyl gallate on H2O2-induced apoptosis in PC12 cellsJames A G Crispo, Matthew Piché, Dominique R Ansell, et al.Cell Death & Disease|June 28, 2019
The interaction between SPARC and GRP78 interferes with ER stress signaling and potentiates apoptosis via PERK/eIF2α and IRE1α/XBP-1 in colorectal cancerYi-Jye Chern, John C T Wong, Grace S W Cheng, et al.Neoplasia (New York, N.Y.)|August 21, 2012
Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivoMahbuba Rahman, Krithika Selvarajan, Mohammad R Hasan, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 5, 2010
The single IgG IL-1-related receptor controls TLR responses in differentiated human intestinal epithelial cellsMohammed A Khan, Theodore S Steiner, Ho Pan Sham, et al.International Journal of Cancer|March 29, 2013
Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53-mediated cellular senescenceJohn C T Wong, Mohammad R Hasan, Mahbuba Rahman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2011
Absence of MMP2 expression correlates with poor clinical outcomes in rectal cancer, and is distinct from MMP1-related outcomes in colon cancerJohn C T Wong, Simon K Chan, David F Schaeffer, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|December 16, 2014
Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancerRobert Neijzen, May Q Wong, Navdeep Gill, et al.Oncotarget|February 4, 2016
Exosomes confer pro-survival signals to alter the phenotype of prostate cells in their surrounding environmentElham Hosseini-Beheshti, Wendy Choi, Louis-Bastien Weiswald, et al.Pageof 4